In this episode, Hannah Imlay, MD, MS, discusses cytomegalovirus (CMV) prevention strategies in solid organ transplantation (SOT) recipients including:Strategies for preventing CMV in SOTInternational guideline recommendations for CMV prevention strategies by organ typeAntivirals used for CMV preventionComparison of preemptive therapy vs prophylaxis for CMV prevention in liver transplant recipientsComparison of letermovir vs valganciclovir for CMV prophylaxis in kidney transplant recipientsUse of CMV cell–mediated immunity monitoring for primary prophylaxisMonitoring CMV viral loads, including limitations to quantitative nucleic acid testingFuture prevention approachesFaculty:Hannah Imlay, MD, MSAssistant Professor of MedicineDepartment of Internal Medicine, Division of Infectious DiseasesUniversity of Utah  Salt Lake City, UtahContent based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.Follow along with a downloadable slideset at: https://bit.ly/476v2wILink to full program: https://bit.ly/47lNK2K